½Å°úÇÐ/öÇÐ
Ãʽɸ®ÇÐ/ÀáÀç´É·Â
UFO/½Å¹°¸®ÇÐ
¿ÀÄÃƼÁò/¹Ì½ºÅ͸®

°úÇÐÀû, ºñ°úÇÐÀû ÀÇÇÐ
µ¿¼­¾ç ´ëüÀÇÇÐ

âÁ¶·Ð/°úÇÐÀû »ç½Ç¼º
âÁ¶·Ð/öÇаú Á¤Ä¡

½ºÄÎƽ½º/±âŸ ÁÖÁ¦
KOPSA ¹Ú¹°°ü

 

´ëÁ߸Åü ¸ð´ÏÅ͸µ
Áú¹®°ú ´ä

Åä·Ð¹æ¹ý
Åä·Ð»ç·Ê

¿¬±¸È¸¿ø °Ô½ÃÆÇ
¿¬±¸À§¿ø °Ô½ÃÆÇ

 

µ¿¼­¾ç ´ëüÀÇÇÐ
   
  ¾ÏÄ¡·á º¸Á¶¹°Áú AHCC, ¼­¿ï³»°ú Àå¼®¿ø ±×¸®°í ±è½Â¿­ÀÇ ÀÌ»óÇÑ ±Û
  ±Û¾´ÀÌ : kopsa     ³¯Â¥ : 06-04-30 19:37     Á¶È¸ : 9349    
 
¾ÏÄ¡·á º¸Á¶¹°Áú AHCC, ¼­¿ï³»°ú Àå¼®¿ø ±×¸®°í ±è½Â¿­ÀÇ ÀÌ»óÇÑ ±Û

¾Æ·¡ ÂüÁ¶ 2´Â ¼ÒÀ§ ´ÙÀ½ Ä«ÆäÀÇ DROFER(±è½Â¿­ Àü¹®ÀÇ)ÀÌ ¾´ ¡°ÇãÀ§ ±¤°í. »ç
±â ±¤°íÀÇ ½Ç¿¹..¡±¶ó´Â ±ÛÀÔ´Ï´Ù. ¡°±¹¹ÎÀϺ¸ 2006.4.25 17ÀÏÀÚ(?) Àü¸é ±¤°í¡±¿¡
°üÇÑ °ÍÀε¥, °­¹Ú»çµµ ÃÖ±Ù¿¡ µ¿¾ÆÀϺ¸¿¡¼­ °°Àº ¾ÏÄ¡·á º¸Á¶¹°ÁúÀ̶ó´Â AHCC
¿¡ °üÇÑ Àü¸é±¤°í¸¦ º» ÀûÀÌ ÀÖ½À´Ï´Ù.

1. ¾ÏÄ¡·á º¸Á¶¹°Áú AHCC

AHCC´Â 3-4³â Àü ¾Æ·¡ Âü°í 1 ÁÖ°£µ¿¾Æ(Á¦353È£/2002.09.26)¿¡ ¡°¾ÏÄ¡·á º¸Á¶
¹°Áú ¡®AHCC¡¯ ¾Æ½Ã³ª¿ä¡±¶ó´Â ±â»ç·Î ¼Ò°³µÈ ÀûÀÌ ÀÖ½À´Ï´Ù. ¾È¿µ¹è ±âÀÚÀÇ ±ÛÀÔ
´Ï´Ù. ÀÌ·¸°Ô µÅ ÀÖ½À´Ï´Ù. ¾Æ·¡ ¡°¾Æ¹Ì³ëÈ­Çл硱°¡ °³¹ßÇß´Ù°í Çߴµ¥ Á¤È®È÷´Â
¡°Amino Up Chemical¡±ÀÔ´Ï´Ù.

¡°AHCC(Active Hexose Correlated Compound)¶õ ÀÙ»õ¡¤Ç¥°í¡¤¿µÁö µîÀÇ ¹ö¼¸ ±Õ
»çü¸¦ ¹è¾çÇÑ ÈÄ È¿¼Ò󸮸¦ ÇÏ¿© ÃßÃâÇس½ º¹ÇÕ´Ù´ç·ù. ...1989³â ȪīÀ̵µ¿¡
±Ù°ÅÁö¸¦ µÐ ¾Æ¹Ì³ëÈ­Çл簡 °³¹ßÇÑ AHCC´Â ¿ø·¡ °£ÀåÁúȯ ¹× ´ç´¢ Ä¡·áÁ¦·Î
ù¼±À» º¸¿´´Ù. ±×·¯´Ù AHCC¸¦ ÀÓ»ó¿¡ Àû¿ëÇغ» °á°ú ¸é¿ªÁõ°­ ÀÛ¿ëÀÌ ÀÖ´Â °Í
À¸·Î ¹àÇôÁü¿¡ µû¶ó ÇöÀç´Â ¾ÏȯÀÚ¿¡ ´ëÇÑ º¸Á¶ Ä¡·á¿ä¹ýÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ
´Ù.¡±

2006³â ÇöÀç´Â Á» ´õ ¸¹Àº °ü·Ã Á¤º¸°¡ ÀÖÀ» °ÍÀ̳ª, ¿©ÇÏÆ° 2002³â ´ç½ÃÀÇ ÀÚ
·á·Î´Â ¡°AHCC Åõ¿©±º¿¡¼­´Â ´ëÁ¶±×·ì¿¡ ºñÇØ Àç¹ß ±â°£ÀÌ ÇöÀúÈ÷ ¿¬ÀåµÆ°í, Àü
üÀûÀÎ »ýÁ¸À²µµ Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¶Ç AHCC¸¦ º¹¿ëÇÑ È¯ÀÚµéÀÇ °æ¿ì ºÎ
ÀÛ¿ëÀÌ ÀüÇô ¾ø¾ú´Ù´Â Á¡¿¡¼­ AHCC°¡ ¾ÏȯÀÚÀÇ »îÀ» ¿¬Àå½ÃÄÑÁÖ´Â º¸Á¶Ä¡·áÁ¦
·Î¼­ °¡Ä¡°¡ ÀÖ´Ù°í ÇÒ ¼ö ÀÖÀ» °ÍÀÌ´Ù.¡±¶ó°í Çß½À´Ï´Ù.

2. ¼­¿ï³»°ú Àå¼®¿ø ¿øÀå

À̹ø µ¿¾ÆÀϺ¸ Àü¸é ±¤°í¿¡´Â ¼­¿ï³»°ú Àå¼®¿ø ¿øÀåÀÇ AHCC ¼Ò°³µµ ÀÖ¾ú´Âµ¥
2002³â ÁÖ°£µ¿¾Æ ±â»ç¿¡µµ Àå¼®¿ø ¿øÀåÀÌ ³ª¿Í ÀÖ½À´Ï´Ù. ´ç½Ã Çмú´ëȸÀÇ Àå
¿øÀåÀÇ ³í¹®Àº ¡°¾ÏȯÀÚ 12¸í¿¡°Ô ÇÏ·ç 3~6gÀÇ AHCC¸¦ Åõ¿©ÇÑ °á°ú¸¦ »ìÆ캻
°Í. ±× °á°ú ÀϹÝÀûÀÎ Ç×¾ÏÄ¡·á¸¦ ¹Þ´Â ȯÀÚÀÇ °æ¿ì´Â ¸é¿ª·ÂÀÌ °¨¼ÒµÇ³ª,
AHCC¸¦ º¹¿ëÇÑ ±×·ì¿¡¼­´Â ¸é¿ª¼öÄ¡°¡ Á¤»ó¹üÀ§¸¦ À¯ÁöÇϰųª ȤÀº »ó½ÂÇÏ´Â
°ÍÀ¸·Î ³ªÅ¸³µ´Ù.¡±´Â °ÍÀε¥, Àå ¿øÀåÀÌ ¿À·¡ ÀüºÎÅÍ AHCC¿¡ °ü½ÉÀ» °¡Áø °ÍÀ¸
·Î º¸ÀÔ´Ï´Ù.

´Ù¸¥ ÀڷḦ ã¾Æº¸´Ï ¡°AHCC ¿¬±¸È¸´Â 1994³â ¹ßÁ·µÇ¾úÀ¸¸ç ¸Å³â ±¹Á¦±Ô¸ðÀÇ
AHCC ¿¬±¸È¸°¡ °³Ãֵǰí ÀÖ½À´Ï´Ù.  2005³â¿¡´Â Á¦ 13ȸ ±¹Á¦ AHCC ¿¬±¸ º¸
°íȸ°¡ ÀϺ» »ñÆ÷·Î¿¡¼­ °³ÃֵǾú½À´Ï´Ù. ÇöÀç À¯·´, ¹Ì±¹ ¹× ij³ª´Ù µîÁö¿¡¼­
±× ¿¬±¸°¡ È°¹ßÇÏ°Ô ÁøÇàµÇ°í ÀÖÀ¸¸ç, ¸¹Àº ¿¬±¸°á°ú ¹× ³í¹®µéÀÌ ¿©·¯ ÇÐȸ¸¦
ÅëÇØ º¸°íµÇ°í ÀÖ½À´Ï´Ù.¡±¶ó°í ÇÕ´Ï´Ù.   
 
3. »ç±â ±¤°í, ÇãÀ§ ±¤°í ½Ç¿¹?

±è½Â¿­ Àü¹®ÀÇ¿¡ °üÇØ ÃÖ±Ù À嵿ÀÍ ½ÅÀÓ ÀÇÇù ȸÀå ±Û¿¡ ÀϺΠÆ÷ÇÔ½ÃÅ°±âµµ Çß
À¸³ª ±è Àü¹®ÀÇ´Â ¡°Åä·Ð »ç·Ê¡± ¡±Åä·Ð ¹æ¹ý¡°¿¡ ºÐ¼®ÇØ ³õÀº ÀÎÅÍ³Ý ºÒ·®¹è¸¦ °Ý
·ÁÇÏ´Â ¹®Á¦¸¦ ¹Ù·Î ¾Ë¾Æ¾ß ÇÕ´Ï´Ù. °­¹Ú»ç´Â ±è½Â¿­ Àü¹®ÀÇÀÇ ÀÌ ¹®Á¦°¡ »ç°í¿Í
ÇൿÀÇ °æ¹Ú¼º°ú °ü·ÃµÆ´Ù°í º¾´Ï´Ù. 

½Ã¸®Áî·Î ´Ù·ç±â À§ÇØ ¿©·¯ »ç·Ê¸¦ º¹»çÇØ µÎ¾úÀ¸³ª À̹ø ±ÛÀº ±× °æ¹Ú¼ºÀÇ ÇÑ
°¡Áö ¿¹ÀÔ´Ï´Ù. ¡°AHCC ³×ÀÌÃÄ¿¡ ½Ç¸®´Ù¡±¶ó´Â °ÍÀε¥, ÀÌ°ÍÀº µ¿¾ÆÀϺ¸ Àü¸é ±¤
°í¿¡µµ ÀÖ¾ú½À´Ï´Ù. ¾Æ·¡ Âü°í 2¿¡´Â ºÐ¸íÈ÷ ¡°Nature 437, 13 October 2005¡±
¡°NATUREJOBS Spotlight on OSAKA"¶ó°í µÅ ÀÖ½À´Ï´Ù. ´Ù½Ã ¸»Çؼ­ ³í¹®À¸·Î
½Ç¸° °ÍÀÌ ¾Æ´Ï°í ¡±Naturejobs"¿¡ ½Ç¸° °ÍÀÔ´Ï´Ù. ¾Æ·¡ Âü°í 4 ¾à¾÷½Å¹®ÀÇ Á¦Ç°
¼Ò°³¿¡µµ µ¿ÀÏÇÑ ³»¿ëÀÌ ÀÖ½À´Ï´Ù. 

±×¸®°í ÀÌ°ÍÀº ¿À»çÄ« »ó°øȸÀǼÒÀÇ ¿À»çÄ«ÀÇ »ý¹° ±â¾÷¿¡ ´ëÇÑ ¼Ò°³ÀÔ´Ï´Ù. ¿¹
¸¦ µé¾î ¿ì¸® È­Çаø¾÷ÀÇ ¿¬±¸¿Í ±â¾÷ ÇöȲ µîÀ» ¼Ò°³ÇÏ´Â ±¤°í°¡ ¹Ì±¹ È­ÇÐȸ
´º½º ·¹ÅÍ¿¡ ½Ç¸° °ÍÀ» º» ÀûÀÌ ÀÖ½À´Ï´Ù. °°Àº Çü½ÄÀÔ´Ï´Ù. ¾Æ·¡ Âü°í 3ÀÇ ±ÛÀ»
º¸½Ê½Ã¿À. °°Àº ¡°Naturejobs Spotlight on Osaka¡±ÀÇ Á¦ÀÏ ¹Ø ºÎºÐÀÇ ¡°Osaka,
Hokkaido and Beyond¡±¶ó´Â ºÎºÐÀÔ´Ï´Ù. AHCC ¼Ò°³°¡ ¿©±â¿¡ ÀÖ½À´Ï´Ù. ±×·¯
´Ï±î ±¤°í¿Í ¿ø¹®ÀÌ ´Ù¸¥ °ÍÀÌ ¾Æ´Õ´Ï´Ù. 

±¹³»¿¡¼­µµ AHCC Á¦Ç°ÀÌ ÆǸŵǰí Àִµ¥, °Ç°­±â´É½ÄÇ°À¸·Î Çã°¡¸¦ ¹Þ¾ÒÀ» °Í
ÀÔ´Ï´Ù. ¾àÀ¸·Î Çã°¡¸¦ ¹ÞÀº °ÍÀÌ ¾Æ´Ï±â ¶§¹®¿¡ Ä¡·á È¿°ú¸¦ ¸»ÇÒ ¼ö´Â ¾ø½À´Ï
´Ù. ±×·¯³ª ½ÇÁ¦ ¾Ï ȯÀÚ¿¡°Ô ¾Æ¹« ¼Ò¿ëÀÌ ¾ø´Ù´À´Ï, µ¶¼ºÀÌ Ä¿¼­ ¹®Á¦°¡ µÈ´Ù´À
´Ï µû¶ó¼­ »ç¿ëÇÏÁö ¸»¶ó°í ¼³µæÇϱ⿡´Â °áÁ¤ÀûÀÎ ÀÚ·á°¡ ¾ø°í ¹Ý¸é¿¡ ÀÌ·± Àú
·± ±àÁ¤ÀûÀÎ ÀÚ·áµµ ÀÖ¾î º¸ÀÔ´Ï´Ù. °¡°Ýµµ ¹®Á¦°¡ µÉ °ÍÀÌÁö¸¸, ¸¸ÀÏ ³»°¡ ¾Ï
ȯÀÚ¶ó¸é AHCC¸¦ »ç¿ëÇÒÁö °¢ÀÚ »ý°¢ÇØ º¸½Ã±â ¹Ù¶ø´Ï´Ù.   

................................................
*Âü°í 1

ÁÖ°£µ¿¾Æ
Á¦353È£/2002.09.26
 
¾ÏÄ¡·á º¸Á¶ ¹°Áú ¡®AHCC¡¯ ¾Æ½Ã³ª¿ä
»ñÆ÷·Î¼­ ±¹Á¦½ÉÆ÷Áö¾ö ¿­·Á ¡¦ ¹ö¼¸ ±Õ»çü ÃßÃâ¹°·Î ìí 700¿©°³ º´¿ø¼­ Ä¡·á
¹ý äÅÃ

ÀϺ» ȪīÀ̵µÀÇ µµÃ» ¼ÒÀçÁöÀÎ »ñÆ÷·Î½Ã. Çظ¶´Ù ´«ÃàÁ¦°¡ ¿­¸®´Â ¿Àµµ¸® °ø¿ø
ÀÌ À¯¸íÇÑ ÀÌ°÷¿¡¼­ Áö³­ 8¿ù ¸»¿¡ Àü ¼¼°è 350¿©¸íÀÇ ÀÇÇÐÀÚµéÀÌ Âü¿©ÇÏ´Â ´ë
±Ô¸ð Çмú´ëȸ°¡ °³ÃֵƴÙ. ¿ÃÇØ·Î 10ȸ°¸¦ ¸Â´Â AHCC¿¬±¸È¸ ±¹Á¦½ÉÆ÷Áö¾öÀÌ
¹Ù·Î ±×°Í.

AHCC(Active Hexose Correlated Compound)¶õ ÀÙ»õ¡¤Ç¥°í¡¤¿µÁö µîÀÇ ¹ö¼¸ ±Õ
»çü¸¦ ¹è¾çÇÑ ÈÄ È¿¼Ò󸮸¦ ÇÏ¿© ÃßÃâÇس½ º¹ÇÕ´Ù´ç·ù. Áï ¿©·¯ Á¾·ùÀÇ ¹ö¼¸À»
ÀÌÁ¾±³¹èÇÔÀ¸·Î½á ¾ò¾îÁö´Â ´ãÀÚ±Õ»çüÀÇ ÃßÃâ¹°À̶ó ÇÒ ¼ö ÀÖ´Ù. 1989³â Ȫī
À̵µ¿¡ ±Ù°ÅÁö¸¦ µÐ ¾Æ¹Ì³ëÈ­Çл簡 °³¹ßÇÑ AHCC´Â ¿ø·¡ °£ÀåÁúȯ ¹× ´ç´¢ Ä¡
·áÁ¦·Î ù¼±À» º¸¿´´Ù. ±×·¯´Ù AHCC¸¦ ÀÓ»ó¿¡ Àû¿ëÇغ» °á°ú ¸é¿ªÁõ°­ ÀÛ¿ëÀÌ
ÀÖ´Â °ÍÀ¸·Î ¹àÇôÁü¿¡ µû¶ó ÇöÀç´Â ¾ÏȯÀÚ¿¡ ´ëÇÑ º¸Á¶ Ä¡·á¿ä¹ýÀ¸·Î ³Î¸® »ç¿ë
µÇ°í ÀÖ´Ù.

AHCC´Â ÇöÀç ÀϺ» ³» 700¿©°³ º´¿ø¿¡¼­ Ä¡·á¹ýÀ¸·Î äÅÃÇÏ°í ÀÖ°í, ¸é¿ªÈ°¼º
È­ ±â´ÉÀÌ ¶Ù¾î³­ ±â´É¼º½ÄÇ°À¸·Îµµ ºÐ·ùµÅ ÀϹÝÀε鵵 ¸¹ÀÌ Ã£´Â´Ù°í ÇÑ´Ù.

AHCC¿¬±¸È¸ °ü°èÀÚ´Â Áö±Ý±îÁö ¼¼°è 8°³±¹ 600¿©°³ º´¿ø¿¡¼­ 5¸¸¸íÀÇ ¾ÏȯÀÚ
µéÀ» ´ë»óÀ¸·Î ÀÌ ¹°Áú¿¡ ´ëÇÑ ±âÃÊ ¹× ÀÓ»ó °á°ú°¡ º¸°íµÆ´Ù°í ¹àÈù´Ù. Çѱ¹¿¡
¼­µµ ÀϺΠÀÇÇÐÀÚµéÀÌ ¾ÏȯÀÚµéÀÇ º¸Á¶ Ä¡·á¿ä¹ýÀ¸·Î½á ÀÌ ¹°Áú¿¡ ´ëÇÑ ¿¬±¸¸¦
ÁøÇàÇÏ°í ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ³´Ù. ÀÌ·¸µí AHCC´Â ¼¼°è °¢±¹ÀÇ ÀÇÇÐÀÚµéÀÌ °ü½É
À» °®°í ÁöÄѺ¸´Â ¹°Áú Áß Çϳª´Ù. ±×·± ¸¸Å­ ¸Å³â ¿­¸®´Â Çмú´ëȸ¿¡¼­´Â
AHCC¿¡ ´ëÇÑ ³î¶ö ¸¸ÇÑ ÀÓ»óº¸°í¼­°¡ ¼Ó¼Ó ¹ßÇ¥µÇ°í ÀÖ´Ù°í ÇÑ´Ù.

º¹¿ëÇÑ ¾ÏȯÀÚµé »ýÁ¸À² Áõ°¡

À̹ø Çмú´ëȸ¿¡¼­ °¡Àå ÁÖ¸ñÀ» ²ö °ÍÀº ÀϺ» °£»çÀÌÀÇ°ú´ëÇÐ °¡¹Ì¾ß¸¶ ¾ß½º¿À
±³¼öÀÇ ³í¹®. °¡¹Ì¾ß¸¶ ±³¼ö´Â ¡®°£¼¼Æ÷¾Ï(°£¾Ï) ¼ö¼ú ȯÀÚÀÇ AHCC¿¡ ÀÇÇÑ ¿¹ÈÄ
°³¼± È¿°ú¡¯¸¦ ÁÖÁ¦·Î ÇÑ ÀÌ ³í¹®À» ÅëÇØ 9³â°£ 222¸íÀÇ °£¾Ï ȯÀÚ¸¦ °üÂûÇÑ °á
°ú¸¦ Àü°Ý °ø°³ÇÔÀ¸·Î½á Âü¼®ÇÑ À̵éÀ» ³î¶ó°Ô Çß´Ù. ¼­¾çÀÇÇÐÀ» Àü°øÇÑ ¿Ü°úÀü
¹®ÀÇÀÎ °¡¹Ì¾ß¸¶ ±³¼ö´Â ¸ÕÀú °£¾Ï ȯÀÚ¸¦ ´Ù·ç´Â ¼­¾çÀÇÇÐÀû Ä¡·á¹ý¿¡ ´ëÇØ ÀÌ
·¸°Ô ¼³¸íÇß´Ù.

¡°°£¼¼Æ÷¾Ï ȯÀÚ¿¡°Ô´Â °£ÀýÁ¦¼ö¼úÀÌ °¡Àå È¿°úÀûÀ̳ª ¼ö¼ú ÈÄ ³ôÀº Àç¹ß·üÀ» º¸
À̸ç, ƯÈ÷ °£°æÈ­³ª ¹ÙÀÌ·¯½º¼º °£¿°À» ÇÔ²² °®°í Àִ ȯÀÚ´Â 5³â À̳» Àç¹ß·ü
ÀÌ 100%¿¡ À̸¥´Ù°í º¸°íµÈ ¹Ù ÀÖ´Ù. ¶Ç ¾ÏÀÇ Àç¹ßÀ» ¿¹¹æÇÏ°í ¾ÏȯÀÚÀÇ »ýÁ¸
À» ¿¬ÀåÇϱâ À§ÇØ È­Çпä¹ýÀÌ ¾²ÀÌ°í ÀÖÀ¸³ª ±× È¿´ÉÀÌ ¸Å¿ì ³·°í ºÎÀÛ¿ëÀÌ ¸¹
À» »Ó¸¸ ¾Æ´Ï¶ó »ýÁ¸ÀÌ ¿¬ÀåµÈ´Ù´Â ¸íÈ®ÇÑ Áõ°Åµµ ¾ø´Ù. Ç×¾ÏÁ¦¸¦ Åõ¿©ÇÏ´Â °æ¿ì
µµ ¾ÏȯÀÚÀÇ Ç׾ϸ鿪 ¹ÝÀÀÀ» °¨¼Ò½ÃÅ°´Â ¿ªÀÛ¿ëÀÌ ÀÖ´Ù. ¿ÀÈ÷·Á ¼ö¼úÇÑ È¯ÀÚ¿¡
°Ô ¸é¿ª¾ïÁ¦Á¦¸¦ »ç¿ëÇÏ´Â °ÍÀÌ ¾Ç¼º Àç¹ßÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ´Ù. µû¶ó¼­ ÀüÅëÀûÀÎ
Ä¡·á¼ú°ú´Â ´Ù¸¥ Â÷¿øÀÇ Á¢±ÙÀÌ ÇÊ¿äÇÒ ¼ö¹Û¿¡ ¾ø´Ù.¡±

°¡¹Ì¾ß¸¶ ±³¼ö´Â ÀÌ ¶§¹®¿¡ ¸é¿ª±â´ÉÀÌ ¶³¾îÁø °£ÀýÁ¦¼ö¼ú ÈÄÀÇ ¾ÏȯÀڵ鿡°Ô
¸é¿ªÁõ°­ ±â´ÉÀÌ ÀÖ´Â AHCC¸¦ Áö¼ÓÀûÀ¸·Î Åõ¿©ÇÔÀ¸·Î½á ±× »ýÁ¸À²À» È®ÀÎÇغ¸
°íÀÚ Çß´Ù°í ¹àÈù´Ù. 1992³â 2¿ùºÎÅÍ 2001³â 12¿ù±îÁö ¹«·Á 9³â°£¿¡ °ÉÄ£ ÀÌ
½ÇÇè¿¡ Âü°¡ÇÑ ¾ÏȯÀÚµéÀº ¸ðµÎ 222¸í. ÀÌÁß 113¸íÀº ȯÀÚ ½º½º·ÎÀÇ ¼±Åÿ¡ µû
¶ó ÇÏ·ç 3g¾¿ AHCC¸¦ º¹¿ëÇß°í, ³ª¸ÓÁö 109¸íÀº ¼ö¼ú ÈÄ AHCC¸¦ º¹¿ëÇÏÁö
¾ÊÀº ´ëÁ¶±×·ìÀ¸·Î¼­ ½ÇÇè¿¡ ÀÀÇß´Ù.(ÀÓ»ó½ÇÇè Ãʱ⿡´Â ´ëÁ¶±ºÀÇ È¯ÀÚµéÀÌ ¸¹¾Ò
À¸³ª ½ÇÇèÀÌ ÁøÇàµÉ¼ö·Ï AHCCÅõ¿©±ºÀ¸·Î º¯°æÇÑ È¯ÀÚµéÀÌ ¸¹¾ÆÁ® ¼ýÀÚ¿¡ ´Ù¼Ò
º¯È­°¡ ÀÖÀ½)

9³â°£ÀÇ ÀÓ»ó½ÇÇè °á°ú´Â ¸Å¿ì Ãæ°ÝÀûÀ̾ú´Ù. AHCC¸¦ º¹¿ëÇÏÁö ¾ÊÀº ´ëÁ¶±ºÀÇ
°æ¿ì ÀÓ»ó½ÇÇè ±â°£(117°³¿ù) ³» ¾ÏÀÌ Àç¹ßÇÑ È¯ÀÚ°¡ 72¸í, »ç¸ÁÇÑ È¯ÀÚ°¡ 51¸í
¿¡ ´ÞÇÑ ¹Ý¸é, AHCCÅõ¿©±ºÀÇ °æ¿ì Àç¹ßȯÀÚ´Â 39¸í, »ç¸ÁȯÀÚ´Â 23¸í¿¡ ºÒ°úÇß
´Ù.

ÀÌ °°Àº °¡¹Ì¾ß¸¶ ±³¼öÀÇ ³í¹®Àº ±× ÇмúÀû °¡Ä¡°¡ ÀÎÁ¤µÅ À¯·´ÀÇ ±ÇÀ§ ÀÖ´Â ÇÐ
¼úÁöÀÎ °£Àå Àú³ÎÁö(Journal of Hepatology¡¤2002³â 37È£)¿¡ ¼ö·ÏµÇ±âµµ Çß´Ù.

¡°°á°úÀûÀ¸·Î AHCCÅõ¿©±º¿¡¼­´Â ´ëÁ¶±×·ì¿¡ ºñÇØ Àç¹ß ±â°£ÀÌ ÇöÀúÈ÷ ¿¬ÀåµÆ°í,
ÀüüÀûÀÎ »ýÁ¸À²µµ Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¶Ç AHCC¸¦ º¹¿ëÇÑ È¯ÀÚµéÀÇ °æ¿ì
ºÎÀÛ¿ëÀÌ ÀüÇô ¾ø¾ú´Ù´Â Á¡¿¡¼­ AHCC°¡ ¾ÏȯÀÚÀÇ »îÀ» ¿¬Àå½ÃÄÑÁÖ´Â º¸Á¶Ä¡·á
Á¦·Î¼­ °¡Ä¡°¡ ÀÖ´Ù°í ÇÒ ¼ö ÀÖÀ» °ÍÀÌ´Ù.¡±

Èï¹Ì·Ó°Ôµµ ±¹³» ÀÇÇÐÀÚÀÇ ÀÓ»óº¸°í¿¡¼­µµ °¡¹Ì¾ß¸¶ ±³¼öÀÇ ¿¬±¸°á°ú¿Í ºñ½ÁÇÑ
³»¿ëÀÌ ¹àÇôÁ³´Ù. ¼­¿ï³»°úÀÇ Àå¼®¿ø ¹Ú»ç´Â À̹ø Çмú´ëȸ¿¡¼­ ¡®Çѱ¹ ¾ÏȯÀÚµé
¿¡°Ô À־ AHCCÀÇ Ç÷û¸é¿ªÇÐÀû È¿°ú¡¯¶õ ³í¹®À» ¹ßÇ¥Çß´Ù. Àå¹Ú»çÀÇ ÀÓ»ó¿¬
±¸´Â Ç×¾ÏÁ¦³ª ¹æ»ç¼± Ä¡·á¸¦ ¹Þ°í ÀÖ´Â ¾ÏȯÀÚ 12¸í¿¡°Ô ÇÏ·ç 3~6gÀÇ AHCC
¸¦ Åõ¿©ÇÑ °á°ú¸¦ »ìÆ캻 °Í. ±× °á°ú ÀϹÝÀûÀÎ Ç×¾ÏÄ¡·á¸¦ ¹Þ´Â ȯÀÚÀÇ °æ¿ì´Â
¸é¿ª·ÂÀÌ °¨¼ÒµÇ³ª, AHCC¸¦ º¹¿ëÇÑ ±×·ì¿¡¼­´Â ¸é¿ª¼öÄ¡°¡ Á¤»ó¹üÀ§¸¦ À¯ÁöÇÏ
°Å³ª ȤÀº »ó½ÂÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.

¡°°£°æÈ­¡¤´ç´¢ µî¿¡µµ È¿°ú ÀÖ´Ù¡±

¡°ÀÎüÀÇ ¸é¿ª±â´ÉÀº Å©°Ô B¸²ÇÁ±¸°¡ ´ã´çÇϴ ü¾×¼º¸é¿ª°ú T¸²ÇÁ±¸°¡ ´ã´çÇÏ
´Â ¼¼Æ÷¼º¸é¿ªÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¾ÏȯÀڴ ü¾×¼º¸é¿ª±â´Éº¸´Ù ¼¼Æ÷¼º¸é¿ª±â´É
ÀÌ Á¤»óÀο¡ ºñÇØ ÇöÀúÈ÷ ÀúÇϵŠÀÖÀ¸¸ç, ÀÌ´Â ¾ÏÀÌ ÁøÇàµÉ¼ö·Ï ´õ¿í ¾ÇÈ­µÈ´Ù.
¶Ç ÀÌ ¼¼Æ÷¼º¸é¿ª±â´ÉÀº ¾ÏÀÇ ÀüÀÌ¿Í Àç¹ß¿¡µµ °ü¿©ÇÏ°Ô µÇ¹Ç·Î ȯÀÚÀÇ »ýÁ¸¿¡
Á÷Á¢ÀûÀÎ ¿µÇâÀ» ÁÖ´Â ¿ä¼ÒÀ̱⵵ ÇÏ´Ù. ±×·±µ¥ AHCC¸¦ º¹¿ëÇÏ´Â ¾ÏȯÀÚµéÀ»
´ë»óÀ¸·Î 3°³¿ù ÁÖ±â·Î Ç÷û ÇÔ·®À» ÃøÁ¤ÇÑ °á°ú, AHCC°¡ ¾ÏȯÀڵ鿡°Ô À¯¿ëÇÑ
»ýüÁ¶Àý¹°Áú(Biological Response Modifiers)ÀÇ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.¡±
Àå¼®¿ø ¹Ú»çÀÇ ¼³¸íÀÌ´Ù.

ÀÌ ¹Û¿¡µµ ¿Ü±¹ ÀÇÇÐÀÚµéÀÇ ¹ßÇ¥¿¡¼­´Â AHCC°¡ ºñ´Ü ¾Ï»Ó¸¸ ¾Æ´Ï¶ó °£°æÈ­ ¹×
°£¿°, ´ç´¢ µî¿¡µµ È¿°ú°¡ ÀÖ´Ù´Â ³»¿ëÀÌ ½ñ¾ÆÁ® ³ª¿Ô´Ù. ¹Ì±¹ÀÇ F. Æ佺īƮ·Î
¹Ú»ç(³»°úÀü¹®ÀÇ¡¤¾ÆÅäŲ½º¼¾ÅÍ º´¿ø)´Â ¡°ÀϺ»¿¡¼­´Â AHCC°¡ ÁÖ·Î ¾Ï Ä¡·á¿¡ »ç
¿ëµÇ°í ÀÖÁö¸¸, ³ª´Â ¾ÏȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó CÇü °£¿°, ½ÉÀ庴, ´ç´¢º´, ¾Ë·¹¸£±â, ¸¸
¼ºÇÇ·Î µî ´Ù¾çÇÑ ÁúȯÀ» ¾Î°í Àִ ȯÀÚ¿¡°Ô »ç¿ëÇÏ°í ÀÖ´Ù¡±¸é¼­ ¡°AHCC´Â ¸Å
¿ì ¶Ù¾î³­ ±â´É¼º½ÄÇ°¡±À̶ó°í ¸»Çß´Ù. ±×´Â ¶ÇÇÑ ÀÚ½ÅÀÌ ¿©·¯ Áúȯ¿¡ AHCC¸¦
Àû¿ëÇÏ°í ÀÖÁö¸¸, ¸Å³â ¿­¸®´Â AHCCÇмú´ëȸ¿¡¼­ ¿©·¯ ÀÇÇÐÀڵ鿡 ÀÇÇØ »õ·Î¿î
ÀÛ¿ë°ú È¿°ú°¡ ¹ßÇ¥µÅ ³î¶óÁö ¾ÊÀ» ¼ö ¾ø¾ú´Ù°í ¸»Çϱ⵵ Çß´Ù. ±×´Â ¾ð·Ð°úÀÇ
ÀÎÅͺ信¼­ ¡°¹Ì±¹ÀÇ °æ¿ì AHCC°¡ ±â´É¼º½ÄÇ°À¸·Î ºÐ·ùµÅ ÆǸŵǰí ÀÖÁö¸¸ ½ÇÁ¦
·Î´Â °Ç°­º¸Á¶½ÄÇ°ÀÇ ¿µ¿ªÀ» ³Ñ¾î¼­ ¿ÀÈ÷·Á ÀǾàÇ°¿¡ °¡±î¿î ÈûÀ» °¡Áö°í ÀÖ´Â
°Í °°´Ù¡±°í ¸»Çß´Ù.

¶Ç º¸¿Ï¡¤´ëü¿ä¹ýÀ¸·Î À¯¸íÇÑ ¸ß½ÃÄÚ ¿À¾Æ½Ã½º º´¿øÀÇ ÇÁ¶õ½Ã½ºÄÚ ÄÜÆ®·¹¶ó½º ¹Ú
»ç´Â AHCC¸¦ º¹¿ëÇÑ ¾ÏȯÀÚ ±×·ì¿¡¼­´Â Ç×¾ÏÁ¦ Ä¡·á¿¡¼­ ¿À´Â ¿À½É(ÀÏÁ¾ÀÇ ±¸
Åä Áõ»ó), ¹«±â·ÂÁõ, Å»¸ð °°Àº ºÎÀÛ¿ëÀÌ °æ°¨µÈ´Ù´Â Èï¹Ì·Î¿î ¿¬±¸µµ ¹ßÇ¥Çß´Ù.

2¹Ú3ÀÏ°£ÀÇ Çмú´ëȸ°¡ ÁøÇàµÇ´Â µ¿¾È Âü¼®ÇÑ ÀÇÇÐÀÚµéÀº ÀÚ½ÅÀÇ ¿¬±¸³í¹® ¹ßÇ¥
°¡ ³¡³­ ÈÄ¿¡µµ ÀÚ¸®¸¦ ¶ßÁö ¾Ê°í ´Ù¸¥ ÀÇÇÐÀÚµéÀÇ ¿¬±¸¸¦ °æûÇÏ°í Áú¹®À» ´ø
Áö±âµµ Çß´Ù. Çѱ¹ÀÇ ÀÇÇÐ Çмú´ëȸ¿¡¼­ ÈçÈ÷ º¼ ¼ö ÀÖ´Â ¸ð½ÀÀÎ, Àڱ⠹ßÇ¥ ¼ø
¼­°¡ ³¡³ª¸é ºÎ¸®³ªÄÉ È¸ÀåÀ» ºüÁ®³ª°¡´Â °Í°ú´Â »ç¹µ ´Ù¸¥ dz°æÀ̾ú´Ù.

¶ÇÇÑ ÀϺ»ÀεéÀÇ ¿¬±¸ ÀÚ¼¼¿¡ ´ëÇØ ºÎ·¯¿î ¸¶À½ÀÌ µé±âµµ Çß´Ù. ¾îÂî º¸¸é Çϳª
ÀÇ ±â´É¼º½ÄÇ°¿¡ ºÒ°úÇÑ AHCC°¡ ¼¼°èÀû ¼öÁØÀÇ ¾Ï Ä¡·á Ưȿ¾àÀ¸·Î ÀÎÁ¤¹Þ°Ô
µÇ±â±îÁö´Â ±âÃÊ¿¡¼­ºÎÅÍ ÀÓ»ó¿¡ À̸£±â±îÁö öÀúÇÏ°Ô ¿¬±¸ÇÏ´Â ±×µéÀÇ ³ë·ÂÀÌ
¸Å¿ì ÄÇ´Ù°í ¾Æ´ÏÇÒ ¼ö ¾ø´Ù.

< »ñÆ÷·Î= ¾È¿µ¹è ±âÀÚ > ojong@donga.com

..............................
*Âü°í 2 ´ÙÀ½ Ä«Æä

ÇãÀ§ ±¤°í. »ç±â ±¤°íÀÇ ½Ç¿¹.. 
±Û¾´ÀÌ : DROFER
³¯Â¥ : 2006.04.25 08:29
 
»ç±â ±¤°í, ÇãÀ§ ±¤°í,,, ¿ø¹®°ú ±¤°í¿¡ ³ª¿Â ¹®¾ÈÀ» ºñ±³ Çغ¸½Ã±â ¹Ù¶ø´Ï´Ù.

¹ö¼¸ ±Õ»çü? ±¹¹ÎÀϺ¸ 2006.4.25 17ÀÏÀÚ Àü¸é ±¤°í

--> ¾ßÈÄ ºí·Î±×¿¡ ÀÌ ±¤°í°¡ ³×ÀÌÃÄ Áö¿¡ ½Ç·È´Ù´Â µ¿ÀÏÇÑ ³»¿ëÀ»
³×ÀÌÃÄ¿¡¼­ ¿ø¹®À» ã¾Æ º½.

2006/01/16 ¿ÀÀü 11:27 | AHCC

"AHCC" ³×ÀÌÃÄ¿¡ ½Ç¸®´Ù.

Nature´Â 1869³â¿¡ ·±´ø¿¡¼­ â°£ µÈ ÀÌ·¡ ´ë·« 130³â°£¿¡ °ÉÃÄ, ¼¼°è No.1ÀÇ
°úÇÐ ÀâÁö·Î¼­ ÃâÆǵǰí ÀÖ½À´Ï´Ù. ³í¹® ¸¸ÀÌ ¾Æ´Ï°í, ¿Â ¼¼»óÀÇ °úÇÐ ´º½º, °úÇÐ
Á¤Ã¥µîµµ äÅÃÇÏ°í ÀÖ¾î °úÇÐÀÚ¡¤¿¬±¸ÀÚ»Ó¸¸ÀÌ ¾Æ´Ï¶ó °úÇп¡ °ü½ÉÀÌ ÀÖ´Â ¸ðµç
»ç¶÷µé¿¡°Ô À־ ³ôÀº Æò°¡¸¦ ¾ò°í ÀÖ´Â Á¤º¸ÁöÀÔ´Ï´Ù.

Nature 437, 13 October 2005,

NATUREJOBS "Spotlight on OSAKA" p22º¸´Ù(¹ø¿ª¹®)

¡¸ÈªÄ«À̵µÀÇ ¹ÙÀÌ¿À »ê¾÷Àº °ßÁ¶ÇÏ°Ô ¼ºÀåÇØ ¿Ô´Ù.1999³â¿¡´Â ¹ÙÀÌ¿À ±â¾÷Àº
34»ç¿´Áö¸¸, 2004³â¿¡´Â 75»ç±îÁö Áõ°¡Çß´Ù.ȪīÀ̵µ, ¿À»çÄ«, ¹Ì±¹ 12»çÀÇ ¹Ù
ÀÌ¿À ±â¾÷¿¡ ÅõÀÚÇÏ°í Àִ ȪīÀ̵µ º¥Ã³ ijÇÇÅÐ »çÀå, ¸¶Ã÷´ÙÀÏ Å¸Ä«½Ã¾¾´Â¡°¿¾
ºÎÅÍ ÀǾàÇ° Á¦Á¶ÀÇ Áß½ÉÁö¿¡¼­ ¸¸³­ ¿À»çÄ«¿Í ´Þ¸®, ȪīÀ̵µÀÇ ¹ÙÀÌ¿À ±â¾÷Àº,
dzºÎÇÑ Ãµ¿¬ÀÚ¿øÀ̶ó°í ÇÏ´Â ¿ìÀ§¼ºÀ» »ì·Á °Ç°­½ÄÇ°À̳ª ½ÄÇ°¿¡ ÈûÀ» ¾²°í ÀÖ
´Ù¡±¶ó°í ¸»ÇÏ°í ÀÖ´Ù.

±× Áß¿¡¼­µµ, ¹ö¼¸°è ±Õ»çüÀÇ ¹è¾ç¿¡ ÀÇÇØ °Ç°­½ÄÇ°À» Á¦Á¶ÇÏ°í ÀÖ´Â ¾Æ¹Ì³ë¾÷
È­ÇÐÀÌ Æ¯È÷ ÇöÀúÇÑ ¼ºÀåÀ» ³ªÅ¸³»°í ÀÖ´Ù°í Àü¹®°¡µîÀº ¸»ÇÑ´Ù.

AHCC·Î ºÒ¸®´Â ¹°ÁúÀº ¸é¿ª±â´ÉÀ» È°¼ºÈ­½ÃÄÑ, Ç×¾ÏÁ¦ÀÇ ºÎÀÛ¿ëÀ» ¿ÏÈ­ÇØ, ¶Ç
°£¿°°ú °°Àº °¨¿°Áõ Ä¡·áÀÇ µµ¿òÀÌ µÈ´Ù. "¿ì¸®´Â º¸¿Ï ´ëü ÀÇ·á¶ó°í ÇÏ´Â °³³ä
À» È®¸³ÇØ ³ª°¡°í ½Í´Ù"¶ó°í ¾Æ¹Ì³ë¾÷È­ÇÐÀÇ ÄÚ½º³ª ÄËÀÌÄ¡ »çÀåÀº ¸»ÇÑ´Ù.

¾Æ¹Ì³ë¾÷È­ÇÐÀÇ ¼º°ø ¿äÀÎÀº, °­°íÇÑ ¸Å´ÏÁö¸ÕÆ®¿Í ÃÖ÷´ÜÀÇ ±Õ»çü ¹è¾ç±â¼ú¿¡
ÀÇÇÏ´Â °ÍÀÌ´Ù. ÇÑÃþ ´õ ÁÖ¸ñÇؾßÇÒ °ÍÀº, 60°³ ÀÌ»óÀÇ ´ëÇÐÀ̳ª º´¿ø¿¡¼­ÀÇ ÀÓ
»ó½ÃÇèÀ» ÅëÇؼ­ ±Û·Î¹úÀÎ ½Å·Ú¼ºÀ» ȹµæÇÏ°í ÀÖ´Â Á¡ÀÌ´Ù. ±× °á°ú, Àǻ糪 ¿¬
±¸ÀÚ°¡ AHCC Á¦Ç°À» »ç¿ëÇÒ ±âȸ°¡ Áõ°¡ÇÏ°í ÀÖ°í, ÇöÀç´Â ¼¼°è 15°³±¹¿¡¼­
AHCC Á¦Ç°ÀÌ ÆǸŵǰí ÀÖ´Ù.

¶Ç, ¾Æ¹Ì³ë¾÷È­ÇÐÀº ½Ä¹°·ÎºÎÅÍ Æú¸®Æä³îÀ» ÃßÃâÇØ, ÀúºÐÀÚÈ­ÇÑ´Ù°í ÇÏ´Â Çõ½ÅÀû
ÀÎ ±â¼úÀ» °³¹ßÇß´Ù. ±× ±â¼ú¿¡ ÀÇÇØ Æú¸®Æä³îÀÇ »ýü Èí¼öÀ²°ú Ç×»êÈ­ ÀÛ¿ëÀÌ
ºñ¾àÀûÀ¸·Î Çâ»óÇÑ´Ù°í ÇÑ´Ù.

http://kr.blog.yahoo.com/gonmisonara/7.html

---------------------------------------
¿ø¹® Ãâó ¸µÅ©¿Í ¿ø¹®
http://www.nature.com/naturejobs/2005/051013/full/nj0093.html

Spotlight on Osaka

Osaka Chamber of Commerce and Industry (Occi) The People's Key
Mover, Promoting The Bioindustries in Osaka
North Osaka, rich in potential, Home to a growing world-class biotech
cluster

North Osaka—the hub of drug companies, academic and research
institutions

North Osaka is home to Osaka University, the National Cardiovascular
Center and numerous other academic and research institutions conducting
world-class research. The surrounding areas of Kyoto, Kobe and Nara
also have research bodies and industries of the biotech sector.

Worthy of special note is Doshomachi, an area in central Osaka City.

Osaka has long been a leading center of commerce in Japan, where rice
and many other commodities were gathered and then distributed to other
parts of the country. It was highly prosperous in the Edo era and
Doshomachi attracted manufacturers and wholesalers of drugs. To this
day, the area is a hub of major pharmaceutical companies on a scale
rarely found in the world. It plays no small part in the economic vitality
of Osaka.

Capitalizing on such potential, a plan to create a world-class bio-cluster
in North Osaka galvanized into action at the start of the 21st century.The
OCCI set up the Bioindustry Promotion Committee as a vehicle for
realizing the plan, adopting promotion strategies, campaigning with central
government, organizing platforms for bio-industry promotion and much
more.

Tanabe Seiyaku Co., Ltd a key Doshomachi company The second oldest
pharmaceutical company in the world

Tanabe Seiyaku Co., Ltd. was the first company in Japan that engaged in
the manufacture and selling of drugs.

Tanabeya Matazaemon, a business tycoon, obtained a trade license from
the Shogun in 1604 and started trading drugs and other products with
parts of Asia. In 1678, his descendent, Tanabeya Gohei, started making
and selling a herbal composite in Tosabori (near Doshomachi). This is
how Tanabe Seiyaku began. It has one of the longest histories among
pharmaceutical companies in the world. to-day, it plays a key role in
Doshomachi and together with Takeda Pharmaceutical Company Limited
has been a keen and full supporter of the North Osaka Biocluster Project
since its inception.

Tanabe Seiyaku is well known as the originator of Diltiazem. It is now
directing its energy into the marketing of Remicade, a remedy for Crohn's
disease and rheumatoid arthritis. Among drugs under developed are
Roflumilast (now in its fi nal clinical study phase), a therapeutic agent for
asthma and COPD, and highly innovative drugs with unique mechanism of
action for diabetes and pollakiuria. In research, extensive alliances with
Japanese and foreign companies and institutes have been formed in the
pursuit of leading-edge drug development research.

Deeply rooted in Osaka, Tanabe Seiyaku is helping to create the North
Osaka Bio-cluster, so as to provide new and excellent products to the
world.

North Osaka Bio-cluster High hopes from pharmaceutical companies

It is becoming increasingly difficult for an individual pharmaceutical
company to develop a new drug due to the difficulty in finding "seeds" or
due to limited funds. In order to reduce the risks of development and to
ensure a higher success rate of new drug candidates, good liaison is
essential among industrial, academic and government sectors.

The North Osaka Bio-cluster, exemplary in this respect, has raised great
hopes of innovative drug development. The OCCI has taken on the role of
coordinator, providing support by offering various platforms.

The North Osaka Bio-cluster hopes that pharmaceutical companies and
other bio-clusters, irrespective of Japanese and foreign, will form
partnerships that will lead to the creation of new drugs, in turn
generating opportunities for widening the vision of Osaka researchers.

TANABE SEIYAKU CO.,LTD.
2-10, Dosho-machi 3-chome, Chuo-ku, Osaka 541-8505, Japan
Tel.:+81-6-6205-5555
URL:http://www.tanabe.co.jp

............................
* Âü°í 3

Naturejobs
Spotlight on Osaka advertising feature
Osaka Chamber of Commerce and Industry (Occi) The People's Key
Mover, Promoting The Bioindustries in Osaka

Osaka, Hokkaido and Beyond
Osaka's biotech prowess draws plenty of collaborations with other biotech
clusters, and the northern island of Hokkaido is one of the most
productive. It has been strengthening ties with Osaka-based universities
and companies through joint research, capital alliances and sponsorships
for college lectures.

But few people outside the region may notice that the remote, spacious
island, which resembles Denmark in economic size and activities, is
quietly trying to make itself a massive research and business centre for
biotechnology. Beset by the sluggish economy that relies on agriculture
and small businesses, Hokkaido is betting on biotech as a pillar of the
future growth engine.

In fact, the biotech industry in Hokkaido has been growing steadily. The
number of biotech companies totaled 75 in 2004, up from 34 in 1999.
"Unlike Osaka, which is strong in drug development, Hokkaido takes
advantage of ample natural resources," says Ikkei Matsuda, president of
Hokkaido Venture Capital, which invests in a dozen biotech companies in
Hokkaido, Osaka and the U.S. Many of Hokkaido's biotech firms focus on
nutraceuticals and food products.

For example, industry experts say Amino Up Chemical, which mainly
produces a nutritional supplement made from mycelia of shiitake
mushroom, is fiourishing. The compound, called Active Hexose Correlated
Compound (AHCC), can activate immunocytes, alleviating side-effects of
anticancer drugs and helping to cure infectious diseases like hepatitis.
"We want to entrench the concept of complementary and alternative
medicine," says president Kenichi Kosuna.

The 50-employee company's success lies largely in solid management
and cutting-edge technology to culture mycelia. More notably, thorough
clinical research at more than 60 universities and hospitals around the
globe has established its credibility. So, doctors are increasingly using
AHCC products, which are now selling in 15 countries. Also, Amino Up
has recently developed a novel technology to extract polyphenol from
plants and break polymers into smaller particles, which can boost
polyphenol's systemic absorption and its antioxidant effect.

Primary Cell, a university start-up armed with nine employees, is also
looking to explore new business areas. The company produces
custom-made primary culture cells from bone, liver and other organs of
lab animals for use in screening drug candidates. Last year, it developed
the world's first system to culture primary cells of visceral adipocyte.
President Toshio Taira says there is great demand for means of
screening drug candidates for diabetes and other metabolic syndromes.
The company is also developing primary culture cells of gastrointestinal
tracts, as demand is rising from food makers to examine specifically how
nutrition is absorbed or discharged.

Meanwhile, the prestigious Hokkaido University, together with government
and industry, is trying to establish a large research and business park
around its campus. The area houses various state-of-the-art facilities
including the Frontier Research Center for Post-Genomic Science and
Technology, whose mainstream research areas include glycol and lipid
engineering.

The university is eager to improve efficiency. It has recently established
an organization called Creative Research Initiative "Sousei" to break down
barriers among faculties, support technology transfer from academic to
industry and encourage human interaction. Already, a few large
manufacturers have set up labs there, but the university hopes its
renewed efforts will lure more private investment. "We believe companies
can easily envisage a business model from science to the market by
joining hands with Hokkaido University," says Hiroshi Takahashi, director
of Sousei.

Contact: Takashi Fujita, International Account Manager, Amino Up
Chemical,
High Tech Hill Shin-ei, 363-32 Shin-ei, Kiyota, Sapporo, 004-0839 Japan
(81)11-889-2555 au_office@aminoup.co.jp

...........................
*Âü°í 4

¾à¾÷½Å¹® 2006.04.13
Á¦Ç°Á¤º¸(Detail)
À̾ؿ¡ÇÁ¸Þµñ½º / »ýüÁ¶Àý¹°Áú 'AHCC'
¸é¿ª¿ä¹ý ´ëÇ¥ÁÖÀÚ¡¦¾ÏȯÀÚ À§ÇÑ À£ºù ½ÄÇ° 

(Áß°£ »ý·«)
 
AHCC..³×ÀÌÃÄ¿¡µµ ¼Ò°³

AHCC¿Í ±× Á¦Á¶È¸»ç((ÁÖ)¾Æ¹Ì³ë¾÷È­ÇÐ)´Â Àü¹® °úÇÐ Àú³ÎÁö 'Nature'¿¡µµ ¼Ò°³µÈ ¹Ù ÀÖ´Ù.

Nature 437, 13 October 2005NATUREJOBS "Spotlight on OSAKA" p22(¹ø
¿ª¹®) ´Â <ȪīÀ̵µÀÇ ¹ÙÀÌ¿À »ê¾÷Àº °ß°íÇÏ°Ô ¼ºÀåÇØ ¿Ô´Ù.1999³â¿¡´Â ¹ÙÀÌ¿À
±â¾÷Àº 34°³»ç¿´Áö¸¸, 2004³â¿¡´Â 75°³»ç±îÁö Áõ°¡Çß´Ù. ȪīÀ̵µ, ¿À»çÄ«, ¹Ì
±¹ 12»çÀÇ ¹ÙÀÌ¿À ±â¾÷¿¡ ÅõÀÚÇÏ°í Àִ ȪīÀ̵µ º¥Ã³ ijÇÇÅÐ »çÀå, ¸¶Ã÷´ÙÀÏ
Ÿī½Ã¾¾´Â ?¿¾ºÎÅÍ ÀǾàÇ° Á¦Á¶ÀÇ Áß½ÉÁö¿¡¼­ ¸¸³­ ¿À»çÄ«¿Í ´Þ¸®, ȪīÀ̵µÀÇ
¹ÙÀÌ¿À ±â¾÷Àº, dzºÎÇÑ Ãµ¿¬ÀÚ¿øÀ̶ó°í ÇÏ´Â ¿ìÀ§¼ºÀ» »ì·Á °Ç°­½ÄÇ°À̳ª ½ÄÇ°¿¡
ÈûÀ» ¾²°í ÀÖ´Ù?¶ó°í ¸»ÇÏ°í ÀÖ´Ù. ±× Áß¿¡¼­µµ, ¹ö¼¸°è ±Õ»çüÀÇ ¹è¾ç¿¡ ÀÇÇØ
°Ç°­½ÄÇ°À» Á¦Á¶ÇÏ°í ÀÖ´Â ¾Æ¹Ì³ë¾÷ È­ÇÐÀÌ Æ¯È÷ ÇöÀúÇÑ ¼ºÀåÀ» ³ªÅ¸³»°í ÀÖ´Ù
°í Àü¹®°¡µîÀº ¸»ÇÑ´Ù.¾Æ¹Ì³ë¾÷ È­ÇÐÀÇ ¼º°ø ¿äÀÎÀº, °­°íÇÑ ¸Å´ÏÁö¸ÕÆ®¿Í ÃÖ÷
´ÜÀÇ ±Õ»çü ¹è¾ç ±â¼ú¿¡ ÀÇÇÏ´Â °ÍÀÌ´Ù. ÇÑÃþ ´õ ÁÖ¸ñ ÇØ¾ß ÇÒ °ÍÀº, 60°³ÀÌ»ó
ÀÇ ´ëÇÐÀ̳ª º´¿ø¿¡¼­ÀÇ ÀÓ»ó½ÃÇèÀ» ÅëÇؼ­ ±Û·Î¹úÀÎ ½Å·Ú¼ºÀ» ȹµæÇÏ°í ÀÖ´Â
Á¡ÀÌ´Ù>°í ¼Ò°³Çß´Ù.

Çѱ¹ º¸¿Ï´ëüÀÇÇÐ ¿¬±¸¼Ò ¼³¸³

ÀϺ» (ÁÖ)¾Æ¹Ì³ë¾÷È­Çп¡¼­´Â ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇг»¿¡ º¸¿Ï´ëü¿¬±¸¼Ò¸¦ ¼³¸³ÇÏ
¿´´Ù. ÀÌ´Â ÃÖ±Ù ÀϺ» ¿À»çÄ«´ëÇп¡¼­ AHCC¸¦ ºñ·ÔÇÑ º¸¿Ï´ëü°ü·Ã½ÄÇ°¿¡ ´ëÇØ
Àӻ󿬱¸¸¦ ½ÃÀÛÇÑ °Í°ú °°Àº ÀÇÀǸ¦ °®°Ô µÈ´Ù. Áï, ÀÇ·á°è¿¡¼­ º¸¼öÀûÀÎ °ÍÀ¸
·Î ¾Ë·ÁÁø ´ëÇеéÀÌ ÀÌÁ¦ º¸¿Ï´ëüÀÇÇÐÂÊ¿¡ °ü½ÉÀ» °®°Ô µÇ¾ú´Ù´Â »ç½ÇÀÌ´Ù. µû
¶ó¼­, À̹ø º¸¿Ï´ëüÀÇÇÐ ¿¬±¸¼Ò ¼³¸³À¸·Î ¸¹Àº ÀÇ·áÁø ¹× ȯÀÚµéÀÇ °ü½ÉÀÌ ¸ð¾Æ
Áö°í ÀÖ´Ù.

º¸¿Ï´ëüÀÇÇבּ¸¼Ò´Â ¼³¸³¸ñÀû¿¡¼­ ¡âµ¿¾çÀÇÇÐ ¹× º¸¿ÏÀÇÇÐÀÇ È¿°ú¼º°ú ¾ÈÀü¼º
¿¡ °üÇÑ ¿¬±¸ ¡âÀÇ°ú´ëÇÐ ¹× ÀÇ°ú´ëÇпø³» µ¿¾çÀÇÇÐ.º¸¿ÏÀÇÇÐ ±³À° °³¹ß ¡âÀÓ»ó
Àû È¿°ú¿Í ¾ÈÀü¼ºÀÌ °ËÁõµÈ µ¿¾ç.º¸¿ÏÀÇÇÐÀÇ ÀÓ»óÀû¿ë ¡âµ¿.¼­º¸¿ÏÀÇÇÐÀÇ À¶ÇÕÀ»
ÅëÇÑ ÀÇ·á ÀÏ¿øÈ­ ±âÃÊ ¸¶·ÃÀ» À§ÇÑ Á¤Ã¥¿¬±¸ ¡âAHCC¿Í °°Àº ±â´É¼º ¼ÒÀç¿¡ °ü
ÇÑ ÀÓ»ó ¹× ¿¬±¸¶ó°í ¹àÈ÷°í ÀÖ´Ù. 
....................